Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT-2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Rajeev Chawla MD FRSSDI FACP (USA) FRCP (Edin) FACE (USA)
Senior Consultant Diabetologist and Director, North Delhi Diabetes Centre, New Delhi, India
Shalini Jaggi Dip Diab (UK) Dip Endo (UK) FRSSDI FRCP (London, Glas, Edin) FACE (USA)
Consultant and Head, Department of Diabetology, Dr Mohans' Diabetes Specialities Centre, New Delhi, India
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New. Bestandsnummer des Verkäufers 40565864-n
Anzahl: Mehr als 20 verfügbar
Anbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers CX-9789352706808
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
Paperback. Zustand: New. SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. They act by inhibiting sodium-glucose transport protein 2 (SGLT2). SGLT2 inhibitors are used in the treatment of type 2 diabetes mellitus.This book is a concise guide to the use of SGLT2 inhibitors for the treatment of diabetes.Beginning with an overview of the evolution and physiology of SGLT2 inhibitors, the following sections cover the renal, cardiovascular, and metabolic and haemodynamic effects of their use. Adverse effects are also examined.The book concludes with detailed discussion on SGLT2 inhibitor use as a preferred option for management of type 2 diabetes, and currently emerging data for their successful use for treatment of type 1 diabetes.Authored by recognised experts in the field, the book provides clinicians with the latest advances in the field, further enhanced by illustrations and figures to assist learning.Key pointsConcise guide to use of SGLT2 inhibitors for management of diabetesCovers common use for treatment of type 2 diabetes as well as increasing use for type 1 diabetesIn depth discussion on associated systemic effectsHighly illustrated with diagrams and figures. Bestandsnummer des Verkäufers LU-9789352706808
Anzahl: 10 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 40565864
Anzahl: Mehr als 20 verfügbar
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers CX-9789352706808
Anzahl: 15 verfügbar
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Paperback. Zustand: new. Paperback. SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. They act by inhibiting sodium-glucose transport protein 2 (SGLT2). SGLT2 inhibitors are used in the treatment of type 2 diabetes mellitus.This book is a concise guide to the use of SGLT2 inhibitors for the treatment of diabetes.Beginning with an overview of the evolution and physiology of SGLT2 inhibitors, the following sections cover the renal, cardiovascular, and metabolic and haemodynamic effects of their use. Adverse effects are also examined.The book concludes with detailed discussion on SGLT2 inhibitor use as a preferred option for management of type 2 diabetes, and currently emerging data for their successful use for treatment of type 1 diabetes.Authored by recognised experts in the field, the book provides clinicians with the latest advances in the field, further enhanced by illustrations and figures to assist learning.Key pointsConcise guide to use of SGLT2 inhibitors for management of diabetesCovers common use for treatment of type 2 diabetes as well as increasing use for type 1 diabetesIn depth discussion on associated systemic effectsHighly illustrated with diagrams and figures Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT-2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9789352706808
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Bestandsnummer des Verkäufers ria9789352706808_new
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 40565864-n
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 40565864
Anzahl: Mehr als 20 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT-2 inhibitors have. Bestandsnummer des Verkäufers 600526401
Anzahl: Mehr als 20 verfügbar